Page last updated: 2024-08-21

thiazoles and Peripheral Arterial Disease

thiazoles has been researched along with Peripheral Arterial Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Aitken, SJ; Ali, ZS; Billot, L; Bubb, KJ; Chow, C; Figtree, GA; Finemore, M; Golledge, J; Gray, MP; Grieve, SM; Hamburg, N; Harmer, JA; Keech, AC; Mister, R; Patel, S; Puttaswamy, V1
Antman, EM; Bonaca, MP; Braunwald, E; Cunningham, JW; Giugliano, RP; Grosso, MA; Halperin, JL; Lanz, HJ; Murphy, SA; Ruff, CT; Weitz, JI; Wiviott, SD1
Adams, G; Ansel, G; Baumgartner, I; Grosso, M; Jaff, M; Lin, M; Mercur, MF; Minar, E; Moll, F; Nwachuku, C; Rundback, J; Tangelder, M; Zeller, T1
Gottsäter, A1
Adams, G; Ansel, G; Baumgartner, I; Duggal, A; Grosso, M; Jaff, M; Mercuri, M; Minar, E; Moll, FL; Nwachuku, CE; Shi, M; Tangelder, MJ1

Trials

4 trial(s) available for thiazoles and Peripheral Arterial Disease

ArticleYear
Protocol for the Stimulating β
    BMJ open, 2021, 09-28, Volume: 11, Issue:9

    Topics: Acetanilides; Clinical Trials, Phase II as Topic; Double-Blind Method; Humans; Multicenter Studies as Topic; Peripheral Arterial Disease; Physical Functional Performance; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-3; Thiazoles; Walking

2021
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48.
    European heart journal. Cardiovascular pharmacotherapy, 2022, Sep-29, Volume: 8, Issue:7

    Topics: Anticoagulants; Atrial Fibrillation; Embolism; Factor Xa Inhibitors; Hemorrhage; Humans; Peripheral Arterial Disease; Pyridines; Stroke; Thiazoles; Warfarin

2022
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial.
    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2018, Volume: 25, Issue:2

    Topics: Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures; Europe; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Israel; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Proof of Concept Study; Prospective Studies; Pyridines; Recurrence; Risk Factors; Thiazoles; Thrombosis; Time Factors; Treatment Outcome; United States; Vascular Patency

2018
A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2015, Volume: 22, Issue:2

    Topics: Aged; Angioplasty; Aspirin; Clopidogrel; Drug Therapy, Combination; Europe; Factor Xa Inhibitors; Female; Femoral Artery; Fibrinolytic Agents; Hemorrhage; Humans; Israel; Male; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Pyridines; Research Design; Risk Factors; Stents; Thiazoles; Ticlopidine; Time Factors; Treatment Outcome; United States

2015

Other Studies

1 other study(ies) available for thiazoles and Peripheral Arterial Disease

ArticleYear
[NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease].
    Lakartidningen, 2018, 12-04, Volume: 115

    Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Cardiovascular Diseases; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Myocardial Infarction; Myocardial Ischemia; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Sweden; Thiazoles

2018